Neurocrine Biosciences
NBIX
#1275
Rank
$13.54 B
Marketcap
$134.57
Share price
0.37%
Change (1 day)
37.53%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - P/B ratio

P/B ratio as of June 2024 : 5.69

According to Neurocrine Biosciences 's latest financial reports the company has a price-to-book ratio of 5.69.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Neurocrine Biosciences - P/B ratio (from 2001 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-315.80-13.73%
2022-12-316.7214.33%
2021-12-315.88-26.05%
2020-12-317.95-48.94%
2019-12-3115.615.47%
2018-12-3113.5-26.91%
2017-12-3118.572.81%
2016-12-3110.7-7.13%
2015-12-3111.540.46%
2014-12-318.1956.68%
2013-12-315.2262.26%
2012-12-313.22-58.81%
2011-12-317.82-63.93%
2010-12-3121.7-28.38%
2009-12-3130.3801%
2008-12-313.36129.43%
2007-12-311.4616.64%
2006-12-311.26-78.98%
2005-12-315.9730.56%
2004-12-314.57-7.13%
2003-12-314.92-21.13%
2002-12-316.24

P/B ratio for similar companies or competitors

Company P/B ratio differencediff. Country
1.70-70.13%๐Ÿ‡บ๐Ÿ‡ธ USA
37.7 561.83%๐Ÿ‡บ๐Ÿ‡ธ USA
65.2 1,045.37%๐Ÿ‡บ๐Ÿ‡ธ USA
3.49-38.68%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.0229-100.40%๐Ÿ‡บ๐Ÿ‡ธ USA
2.60-54.29%๐Ÿ‡บ๐Ÿ‡ธ USA
19.6 244.73%๐Ÿ‡บ๐Ÿ‡ธ USA
1.62-71.63%๐Ÿ‡ฌ๐Ÿ‡ง UK